Loading...
XNYS
ITGR
Market cap4.23bUSD
Jun 06, Last price  
121.33USD
1D
0.36%
1Q
-0.52%
Jan 2017
311.99%
IPO
495.05%
Name

Integer Holdings Corp

Chart & Performance

D1W1MN
XNYS:ITGR chart
No data to show
P/E
35.31
P/S
2.47
EPS
3.44
Div Yield, %
Shrs. gr., 5y
1.53%
Rev. gr., 5y
6.41%
Revenues
1.72b
+7.51%
241,097,000271,142,000318,746,000546,644,000521,821,000533,425,000568,822,000646,177,000663,945,000687,787,000800,414,0001,386,778,0001,461,921,0001,215,012,0001,258,094,0001,073,442,0001,221,079,0001,376,096,0001,596,673,0001,716,596,000
Net income
120m
+32.26%
10,107,00016,126,00015,050,00018,559,000-9,001,00033,138,00033,122,000-4,799,00036,267,00055,458,000-7,594,0005,961,00066,679,000167,964,00096,336,00077,258,00096,808,00066,377,00090,650,000119,896,000
CFO
205m
+13.87%
43,335,00039,205,00042,965,00057,101,00071,766,00076,885,00089,921,00064,831,00056,755,00081,276,00012,479,000105,532,000149,357,000167,299,000165,358,000181,341,000156,666,000116,381,000180,213,000205,205,000
Earnings
Jul 23, 2025

Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
IPO date
Sep 29, 2000
Employees
10,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122016‑00
Income
Revenues
1,716,596
7.51%
1,596,673
16.03%
1,376,096
12.70%
Cost of revenue
1,311,007
1,242,155
1,078,008
Unusual Expense (Income)
NOPBT
405,589
354,518
298,088
NOPBT Margin
23.63%
22.20%
21.66%
Operating Taxes
26,510
16,644
10,608
Tax Rate
6.54%
4.69%
3.56%
NOPAT
379,079
337,874
287,480
Net income
119,896
32.26%
90,650
36.57%
66,377
-31.43%
Dividends
Dividend yield
Proceeds from repurchase of equity
(3,098)
(2,779)
BB yield
0.09%
0.12%
Debt
Debt current
17,352
10,586
28,550
Long-term debt
1,190,429
1,135,965
1,061,545
Deferred revenue
160,671
Other long-term liabilities
25,360
14,365
(147,292)
Net debt
1,161,238
1,111,049
1,051,934
Cash flow
Cash from operating activities
205,205
180,213
116,381
CAPEX
(119,938)
(74,728)
Cash from investing activities
(195,414)
(163,367)
(200,421)
Cash from financing activities
13,321
(18,014)
92,476
FCF
270,698
188,681
195,484
Balance
Cash
46,543
23,674
24,272
Long term investments
11,828
13,889
Excess cash
Stockholders' equity
877,238
791,607
686,063
Invested Capital
2,743,542
2,586,645
2,427,590
ROIC
14.22%
13.48%
12.23%
ROCE
14.14%
12.98%
11.52%
EV
Common stock shares outstanding
35,649
33,758
33,357
Price
132.52
33.75%
99.08
44.73%
68.46
-20.01%
Market cap
4,724,205
41.24%
3,344,743
46.47%
2,283,620
-19.78%
EV
5,885,443
4,455,792
3,335,554
EBITDA
516,620
453,359
390,079
EV/EBITDA
11.39
9.83
8.55
Interest
56,374
53,370
38,632
Interest/NOPBT
13.90%
15.05%
12.96%